Human Genome Epidemiology Literature Finder
Reproductive and Child Health
Records 1 - 13 (of 13 Records) |
Query Trace: Tamoxifen[original query] |
---|
Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group. Lancet (London, England) 2000 Dec 356 (9245): 1876-81. Narod S A, Brunet J S, Ghadirian P, Robson M, Heimdal K, Neuhausen S L, Stoppa-Lyonnet D, Lerman C, Pasini B, de los Rios P, Weber B, Lynch H, |
Tamoxifen and contralateral breast cancer in BRCA1 and BRCA2 carriers: an update. International journal of cancer. Journal international du cancer 2006 May 118 (9): 2281-4. Gronwald Jacek, Tung Nadine, Foulkes William D, Offit Kenneth, Gershoni Ruth, Daly Mary, Kim-Sing Charmaine, Olsson Hakan, Ainsworth Peter, Eisen Andrea, Saal Howard, Friedman Eitan, Olopade Olufunmilayo, Osborne Michael, Weitzel Jeffrey, Lynch Henry, Ghadirian Parviz, Lubinski Jan, Sun Ping, Narod Steven A, |
Association of cyclophosphamide drug-metabolizing enzyme polymorphisms and chemotherapy-related ovarian failure in breast cancer survivors. Fertility and sterility 2010 Jul 94 (2): 645-54. Su H Irene, Sammel Mary D, Velders Luke, Horn Michelle, Stankiewicz Corrie, Matro Jennifer, Gracia Clarisa R, Green Jamie, DeMichele Ange |
Genetic polymorphism of cytochrome P450 2D6 determines oestrogen receptor activity of the major infertility drug clomiphene via its active metabolites. Human molecular genetics 2012 Mar 21 (5): 1145-54. Mürdter Thomas E, Kerb Reinhold, Turpeinen Miia, Schroth Werner, Ganchev Boian, Böhmer Gabriele M, Igel Svitlana, Schaeffeler Elke, Zanger Ulrich, Brauch Hiltrud, Schwab Matthi |
Influence of Val16Ala SOD2 polymorphism on the in-vitro effect of clomiphene citrate in oxidative metabolism. Reproductive biomedicine online 2012 Apr 24 (4): 474-81. Costa Felipe, Dornelles Eduardo, Mânica-Cattani Maria Fernanda, Algarve Thaís Doeller, Souza Filho Olmiro Cezimbra de, Sagrillo Michele Rorato, Garcia Luiz Filipe Machado, Cruz Ivana Beatrice Mânica |
Impact of CYP2D6 polymorphisms on tamoxifen responses of women with breast cancer: a microarray-based study in Thailand. Asian Pacific journal of cancer prevention : APJCP 2012 13 (9): 9. Sukasem C, Sirachainan E, Chamnanphon M, Pechatanan K, Sirisinha T, Ativitavas T, Panvichian R, Ratanatharathorn V, Trachu N, Chantratita W |
Chemotherapy-induced amenorrhea in patients with breast cancer with a BRCA1 or BRCA2 mutation. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013 Nov 31 (31): 3914-9. Valentini Adriana, Finch Amy, Lubinski Jan, Byrski Tomasz, Ghadirian Parviz, Kim-Sing Charmaine, Lynch Henry T, Ainsworth Peter J, Neuhausen Susan L, Greenblatt Ellen, Singer Christian, Sun Ping, Narod Steven |
Risk factors for endometrial cancer among women with a BRCA1 or BRCA2 mutation: a case control study. Familial cancer 2015 Sep 14 (3): 383-91. Segev Yakir, Rosen Barry, Lubinski Jan, Gronwald Jacek, Lynch Henry T, Moller Pal, Kim-Sing Charmaine, Ghadirian Parviz, Karlan Beth, Eng Charis, Gilchrist Dawna, Neuhausen Susan L, Eisen Andrea, Friedman Eitan, Euhus David, Ping Sun, Narod Steven A, |
Genetic polymorphisms of CYP2D6*10 and the effectiveness of combined tamoxifen citrate and testosterone undecanoate treatment in infertile men with idiopathic oligozoospermia. Journal of Zhejiang University. Science. B 2015 Mar 16 (3): 191-7. Tang Kai-fa, Zhao Yi-li, Ding Shang-shu, Wu Qi-fei, Wang Xing-yang, Shi Jia-qi, Sun Fa, Xing Jun-pi |
CYP2D6 Genotype and Risk of Recurrence in Tamoxifen Treated Breast Cancer Patients. Asian Pacific journal of cancer prevention : APJCP 2015 16 (15): 6783-7. Yazdi Mohammad Forat, Rafieian Shiva, Gholi-Nataj Mohsen, Sheikhha Mohammad Hasan, Nazari Tahereh, Neamatzadeh Hosse |
Effects of ospemifene, a novel selective estrogen-receptor modulator, on human breast tissue ex vivo. Menopause (New York, N.Y.) 2016 May . Eigeliene Natalija, Kangas Lauri, Hellmer Christina, Kauko Tommi, Erkkola Risto, Härkönen Pirk |
Quality of Life in a Randomized Breast Cancer Prevention Trial of Low-Dose Tamoxifen and Fenretinide in Premenopausal Women. Cancer prevention research (Philadelphia, Pa.) 2018 10 11 (12): 811-818. Serrano Davide, Gandini Sara, Guerrieri-Gonzaga Aliana, Feroce Irene, Johansson Harriet, Macis Debora, Aristarco Valentina, Bonanni Bernardo, DeCensi Andr |
Genetic predictors of chemotherapy-related amenorrhea in women with breast cancer.
Fertility and sterility 2019 Oct 112 (4): 731-739.e1. Ruddy Kathryn J, Schaid Daniel J, Partridge Ann H, Larson Nicholas B, Batzler Anthony, Häberle Lothar, Dittrich Ralf, Widschwendter Peter, Fink Visnja, Bauer Emanuel, Schwitulla Judith, Rübner Matthias, Ekici Arif B, Aivazova-Fuchs Viktoria, Stewart Elizabeth A, Beckmann Matthias W, Ginsburg Elizabeth, Wang Liewei, Weinshilboum Richard M, Couch Fergus J, Janni Wolfgang, Rack Brigitte, Vachon Celine, Fasching Peter |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: